Mosmiller LT, Steele KN, Shrader CD, et al. Evaluation of inflammatory cell biomarkers in chronic venous insufficiency. Phlebology. Epub ahead of print 1 January 2017: 10.1177/0268355517701806.
2.
YetkinEIleriM. Dilating venous disease: Pathophysiology and a systematic aspect to different vascular territories. Med Hypotheses2016; 91: 73–76.
3.
YetkinEOzturkS. Dilating venous diseases: varicocele and varicose vein. Ann Vasc Surg2017; 38: 348–348.
4.
YetkinEWaltenbergerJ. Novel insights into an old controversy: Is coronary artery ectasia a variant of coronary atherosclerosis?Clin Res Cardiol2007; 96: 331–339.
5.
AfariMEBhatT. Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update. Expert Rev Cardiovasc Ther2016; 14: 573–577.
6.
BaltaSDemirerZAparciMet al.The lymphocyte-monocyte ratio in clinical practice. J Clin Pathol2016; 69: 88–89.
7.
DemircelikBMKurtulAOcekHet al.Association between platelet-to-lymphocyte ratio and contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome. Cardiorenal Med2015; 5: 96–104.